Search Results - "Zorich, N L"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Abdominal pain, bloating, and diarrhea in the United States: Prevalence and impact by SANDLER, R. S, STEWART, W. F, LIBERMAN, J. N, RICCI, J. A, ZORICH, N. L

    Published in Digestive diseases and sciences (01-06-2000)
    “…The prevalence and impact of abdominal pain, bloating, and diarrhea in the adult US population are largely unknown. We conducted a national, cross-sectional,…”
    Get full text
    Conference Proceeding Journal Article
  2. 2

    Review article: olestra and its gastrointestinal safety by THOMSON, A. B. R, HUNT, R. H, ZORICH, N. L

    Published in Alimentary pharmacology & therapeutics (01-12-1998)
    “…Olestra is a fat substitute made from sucrose and vegetable oil. Olestra is neither digested nor absorbed, and therefore adds no calories or fat to the diet…”
    Get full text
    Journal Article
  3. 3

    Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing Olestra or triglycerides : A 6-week randomized, placebo-controlled trial by SANDLER, R. S, ZORICH, N. L, FILLOON, T. G, WISEMAN, H. B, LIETZ, D. J, BROCK, M. H, ROYER, M. G, MIDAY, R. K

    Published in Annals of internal medicine (16-02-1999)
    “…Olestra is a nonabsorbable, energy-free fat substitute. Because it is not absorbed, it may cause digestive symptoms when consumed in large amounts. To compare…”
    Get full text
    Journal Article
  4. 4

    Reaction of discoidal complexes of apolipoprotein A-I and various phosphatidylcholines with lecithin cholesterol acyltransferase. Interfacial effects by Jonas, A., Zorich, N.L., Kézdy, K.E., Trick, W.E.

    Published in The Journal of biological chemistry (25-03-1987)
    “…Complexes of phospholipids-apolipoprotein A-I-cholesterol, containing various bulk phosphatidylcholines or a matrix of the ether analog of 1-palmitoyl 2-oleoyl…”
    Get full text
    Journal Article
  5. 5

    Randomized, Double-Blind, Placebo-Controlled, Consumer Rechallenge Test of Olean Salted Snacks by Zorich, Nora L., Biedermann, David, Riccardi, Karen A., Bishop, Lori J., Filloon, Thomas G.

    Published in Regulatory toxicology and pharmacology (01-10-1997)
    “…Olestra is a zero-calorie fat substitute that is neither digested nor absorbed. A randomized, double-blind, placebo-controlled, within-subject, crossover…”
    Get full text
    Journal Article
  6. 6

    Olestra dose response on fat-soluble and water-soluble nutrients in humans by Schlagheck, T G, Riccardi, K A, Zorich, N L, Torri, S A, Dugan, L D, Peters, J C

    Published in The Journal of nutrition (01-08-1997)
    “…Ninety normal healthy adults were given 0, 8, 20 or 32 g/d olestra for 8 wk as part of a diet that provided 1 +/- 0.2 of the recommended dietary allowance…”
    Get more information
    Journal Article
  7. 7

    Properties of discoidal complexes of human apolipoprotein A-I with phosphatidylcholines containing various fatty acid chains by Zorich, N L, Kézdy, K E, Jonas, A

    Published in Biochimica et biophysica acta (02-06-1987)
    “…In this study we demonstrate that apolipoprotein A-I determined the common size classes of discoidal particles formed with numerous phosphatidylcholines, and…”
    Get more information
    Journal Article
  8. 8

    Postmarketing Surveillance of New Food Ingredients: Results from the Program with the Fat Replacer Olestra by Allgood, Gregory S., Kuter, David J., Roll, Kevin T., Taylor, Steve L., Zorich, Nora L.

    Published in Regulatory toxicology and pharmacology (01-04-2001)
    “…Market introduction of savory snacks containing olestra offered an opportunity to evaluate the safety of olestra in a free-living population and thereby…”
    Get full text
    Journal Article
  9. 9

    Olestra's effect on vitamins D and E in humans can be offset by increasing dietary levels of these vitamins by Schlagheck, T G, Kesler, J M, Jones, M B, Zorich, N L, Dugan, L D, Davidson, M H, Peters, J C

    Published in The Journal of nutrition (01-08-1997)
    “…One hundred two normal healthy males and females were given 0, 8, 20 or 32 g/d olestra to which had been added graded amounts of vitamins A, D and E for 8 wk…”
    Get more information
    Journal Article
  10. 10

    Olestra ingestion and dietary fat absorption in humans by Daher, G C, Cooper, D A, Zorich, N L, King, D, Riccardi, K A, Peters, J C

    Published in The Journal of nutrition (01-08-1997)
    “…The effect of olestra, a zero-calorie fat replacement, on the absorption of dietary fat was determined with a dual-isotope technique in 67 healthy male…”
    Get more information
    Journal Article
  11. 11

    Postmarketing Surveillance of New Food Ingredients: Design and Implementation of the Program for the Fat Replacer Olestra by Slough, Candice L., Miday, Robert K., Zorich, Nora L., Jones, Judith K.

    Published in Regulatory toxicology and pharmacology (01-04-2001)
    “…Following U.S. Food and Drug Administration (FDA) approval for the use of olestra, a noncaloric fat substitute (brand name Olean) in food snacks, the…”
    Get full text
    Journal Article
  12. 12

    Olestra ingestion and retinyl palmitate absorption in humans by Daher, G C, Cooper, D A, Zorich, N L, King, D, Riccardi, K A, Peters, J C

    Published in The Journal of nutrition (01-08-1997)
    “…This study examined the effect of olestra, a zero-calorie fat replacement, on the absorption of retinyl palmitate in humans. After a 30-d adaptation period…”
    Get more information
    Journal Article
  13. 13

    Overview of olestra: a new fat substitute by Hunt, R, Zorich, N L, Thomson, A B

    Published in Canadian journal of gastroenterology (01-04-1998)
    “…Olestra is a mixture of hexa-, hepta- and octa-esters formed from the reaction of sucrase and long chain fatty acids isolated from edible oils. Olestra has…”
    Get full text
    Journal Article
  14. 14

    Follow-Up to the Study: A Randomized, Double-Blind, Placebo-Controlled Consumer Rechallenge Test of Olean Salted Snacks by Zorich, Nora L., Biedermann, David, Riccardi, Karen A., Bishop, Lori J., Filloon, Thomas G.

    Published in Regulatory toxicology and pharmacology (01-02-1998)
    “…Olestra is a zero-calorie fat substitute that is neither digested nor absorbed. We recently reported the results of a rechallenge study that compared the…”
    Get full text
    Journal Article
  15. 15

    A randomized, double-blind study of the effect of olestra on disease activity in patients with quiescent inflammatory bowel disease. Olestra in IBD Study Group by Zorich, N L, Jones, M B, Kesler, J M, Carter, S B, Sutton, M A, Bayless, T

    Published in The American journal of medicine (01-11-1997)
    “…To determine the effects of olestra, a zero-calorie fat substitute that is neither digested nor absorbed, on the well-being and disease state of persons with…”
    Get more information
    Journal Article
  16. 16
  17. 17